AT
The startup operates an image-guided, injectable platform for intratumoral drug delivery, designed to create personalized cancer vaccines targeting both local and metastatic tumors. By facilitating collaboration between clinicians and engineers, the company enhances immune system responses to improve treatment outcomes in cancer care.
Updated 4 months ago
Funding
Funding not disclosed
Funding rounds are not available yet.
Founders
Product
Features
- The startup operates an image-guided, injectable platform for intratumoral drug delivery, designed to create personalized cancer vaccines targeting both local and metastatic tumors. By facilitating collaboration between clinicians and engineers, the company enhances immune system responses to improve treatment outcomes in cancer care.